Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine
- 25 May 1999
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 42 (2) , 97-108
- https://doi.org/10.1016/s0166-3542(99)00009-1
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Impact of Complete Inhibition of Viral Replication on the Cellular Immune Response in Chronic Hepatitis B Virus InfectionHepatology, 1996
- Selection of Mutations in the Hepatitis B Virus Polymerase During Therapy of Transplant Recipients With LamivudineHepatology, 1996
- Potential Role of Lamivudine (3TC) in the Clearance of Chronic Hepatitis B Virus Infection in a Patient Coinfected with Human Immunodeficiency Virus Type 1Clinical Infectious Diseases, 1996
- The Interaction of Human Immunodeficiency Virus Infection and Hepatitis B Virus Infection in Infected Homosexual MenJournal of Clinical Gastroenterology, 1996
- In VivoInhibition of Hepatitis B Virus Gene Expression by Antisense Phosphorothioate OligonucleotidesBiochemical and Biophysical Research Communications, 1996
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- Hbsag Retention Sensitizes the Hepatocyte to Injury by Physiological Concentrations of Interferon–γHepatology, 1992
- Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: Presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infectionsHepatology, 1989
- Development of Disease and Virus Recovery in Transgenic Mice Containing HIV Proviral DNAScience, 1988
- Bovine papillomavirus genome elicits skin tumours in transgenic miceNature, 1986